SingHealth Group / Singapore Health Services
Industry / private company
Location:
Singapore,
Singapore (SG)
ISNI: 000000404699402
ROR: https://ror.org/04me94w47
Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus Statement (2020)
Sagar R, Almeida-Porada G, Blakemore K, Chan JK, Choolani M, Götherström C, Jaulent A, et al.
Journal article, Review article
GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers (2017)
Rasheed SAK, Leong HS, Lakshmanan M, Raju A, Dadlani D, Chong FT, Shannon NB, et al.
Journal article